SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001062993-18-002096
Filing Date
2018-05-11
Accepted
2018-05-11 07:05:39
Documents
11
Period of Report
2018-05-11

Document Format Files

Seq Description Document Type Size
1 FORM 6-K form6k.htm 6-K 5525
2 EXHIBIT 99.1 exhibit99-1.htm EX-99.1 296868
3 EXHIBIT 99.2 exhibit99-2.htm EX-99.2 235715
4 EXHIBIT 99.3 exhibit99-3.htm EX-99.3 6828
5 EXHIBIT 99.4 exhibit99-4.htm EX-99.4 6816
6 EXHIBIT 99.5 exhibit99-5.htm EX-99.5 20727
7 GRAPHIC exhibit99-1x1x1.jpg GRAPHIC 6395
8 GRAPHIC exhibit99-2x1x1.jpg GRAPHIC 6478
9 GRAPHIC exhibit99-2x5x1.jpg GRAPHIC 26257
10 GRAPHIC exhibit99-2x6x1.jpg GRAPHIC 33030
11 GRAPHIC exhibit99-5x1x1.jpg GRAPHIC 4722
  Complete submission text file 0001062993-18-002096.txt   680087
Mailing Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9
Business Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9 (416) 595-0627
Trillium Therapeutics Inc. (Filer) CIK: 0001616212 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1214
Type: 6-K | Act: 34 | File No.: 001-36596 | Film No.: 18824901
SIC: 2834 Pharmaceutical Preparations